Risk guided use of the direct thrombin inhibitor bivalirudin: insights from recent trials and analyses

Por Hillegass, William B., Bradford, Gregory S.
Publicado no J Thorac Dis (2016)

Oral antiplatelet therapy in diabetes mellitus and the role of prasugrel: an overview

Por Hillegass, William B, Brott, Brigitta C, Dobbs, James C, Papapietro, Silvio E, Misra, Vijay K, Zoghbi, Gilbert J
Publicado em 2011

Health Status after Treatment for Coronary Artery Disease and Type 2 Diabetes in the BARI 2D Trial

Por Brooks, Maria Mori, Chung, Sheng-Chia, Helmy, Tarek, Hillegass, William B., Escobedo, Jorge, Melsop, Kathryn A., Massaro, Elaine M., McBane, Robert D., Hyde, Pamela, Hlatky, Mark A.
Publicado em 2010

Precision Medicine at the University of Alabama at Birmingham: Laying the foundational processes through implementation of Genotype-Guided Antiplatelet Therapy

Por Harada, Shuko, Zhou, Yaolin, Duncan, Steve, Armstead, Alicia R., Coshatt, Gina M., Dillon, Chrisly, Brott, Brigitta C., Willig, James, Alsip, Jorge A., Hillegass, William B., Limdi, Nita A.
Publicado no Clin Pharmacol Ther (2017)

The Learning Curve for Transradial Percutaneous Coronary Intervention among Operators in the United States: A Study from the National Cardiovascular Data Registry®

Por Hess, Connie N., Peterson, Eric D., Neely, Megan L., Dai, David, Hillegass, William B., Krucoff, Mitchell W., Kutcher, Michael A., Messenger, John C., Pancholy, Samir, Piana, Robert N., Rao, Sunil V.
Publicado em 2014

Anticoagulation Control in Patients with Ventricular Assist Devices

Por Boehme, Amelia K, Pamboukian, Salpy V., George, James F., Beasley, T. Mark, Kirklin, James K., Tallaj, Jose, Dillon, Chrisly, Levitan, Emily B., Griffin, Russell, McGwin, Gerald, Hillegass, William B, Limdi, Nita A.
Publicado no ASAIO J (2017)